Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Mini review · 30 May 2023Exact title match Commentary · 2021Exact title match Cancer immunotherapy
Conference abstract · 21 Nov 2016Exact title match Cancer immunotherapy
Conference abstract · 20 Mar 2019 Targeted Immunotherapy for Breast Cancer Immunotherapy - Fact, myths and experience: Mythbusters: How beautiful facts can falsify ugly theories
discussion, I will discuss objective findings that refute the following Breast cancer is not immunogenic Targeted Immunotherapy is effective only if <10^6 cells BCG can aid tumor regression ... would neutralize any…
Conference abstract · 3 Oct 2018 Cancer immunotherapy array: A novel screening tool for immune system profiling in cancer immunotherapy bridging autoimmunity and cancer
programmed death 1 (PD-1)/PD-L1 pathway represent milestones in the field of cancer immunotherapy. In general, cancer immunotherapy works only in a subset of patients, but some patients ... experience prolonged…
Conference abstract · 19 May 2016 Mesothelin Expression in Ovarian Cancer and its potential as Targeted Ovarian cancer Immunotherapy
glycosylphosphatidylinositol (GPI) anchored cell surface protein, is a potential target for antibody-based ovarian cancer immunotherapy due to its high expression in ovarian cancer. Mesothelin plays a role in cancer…
Conference abstract · 14 Sep 2016 Hepatotoxicity due to Cancer immunotherapy targeting immune checkpoints
Immunotherapy is a rapidly developing treatment modality for cancer. Of the broad range of immunotherapies presently in clinical development and clinical use those targeting T cell inhibitor receptors, referred
Conference abstract · 17 Jul 2017 Novel antibody for cancer immunotherapy: beyond and synergistic with immune checkpoint blockade therapy
adoptive cell-based therapy pre-clinically. Our study has launched a new avenue of cancer immunotherapy which can be readily translated into clinical trials
Conference abstract · 3 Aug 2015 Cancer immunotherapy utilizing gene-modified T cells: from the bench to the clinic.
Adoptive immunotherapy involving genetic modification of T cells with chimeric antigen receptors (CAR’s) is a promising approach for treatment of cancer although has resulted in on target toxicity
Editorial · 30 Oct 2021 Biomarkers: Cancer Immunotherapy
Commentary · 31 Mar 2023 A New Era in Cancer Immunotherapy: Individualized Cancer Vaccines
Conference abstract · 3 Aug 2015 HER-2/neu as a target for Listeria-based cancer immunotherapy for breast cancer
expressing tumors, such as breast cancer.Lm-LLO-cHER-2/neu,is an Lm-LLO immunotherapy bioengineered to secrete a chimeric polypeptide consisting of three regions of HER-2/neu known ... proven to be effective at limiting…
Conference abstract · 3 Aug 2015 HER-2/neu as a target forListeria-based cancer immunotherapy for breast cancer
over expressing tumors, such as breast cancer.Lm-LLO-cHER-2/neu,is anrnLm-LLO immunotherapy bioengineered to secrete a chimeric polypeptide consisting of three regions of HER-2/neu knownrnto ... proven to be effective…
Conference abstract · 20 Dec 2021 Cancer Immunotherapy: T cell gainst cancer
emphasize the yet to be elucidated questions and future promise within the field of cancer immunotherapy
Research article · 2020 Management of toxicities from Immunotherapy in cancer patients
programmed death-1 receptor (PD-1) are increasingly being used in the treatment of cancer. However , management and recognition of toxicities (Immune related adverse events ) have been a problem ... anticipated and…
Conference abstract · 5 Nov 2018 Multifunctional nanoparticles for cancer immunotherapy: An emerging approach for personalized cancer therapy
stimulant or modulator of the body immune system to fight against or treat cancers. Although targeted immunotherapies such as immune check point inhibitors (CTLA ... mitigated through nanotechnology approaches…
Short communication · 2 Mar 2026 Advances In Cancer Immunotherapy: Biomarkers And Resistance
Perspective · 30 Oct 2025 Personalized Cancer Immunotherapy: Advanced Strategies
Perspective · 30 Oct 2025 Biomarkers Drive Precision Cancer Immunotherapy
Opinion · 29 Sep 2025 Cancer Immunotherapy Costs: Real-world Economic Considerations
Research article · 29 Aug 2025 Ovarian Cancer Immunotherapy: Overcoming Resistance, Predicting Response
ovarian cancer by reactivating anti-tumor immunity, but the immunosuppressive tumor microenvironment poses a challenge for durable efficacy. Combination strategies with chemotherapy, targeted therapies, and other…
Short communication · 29 Aug 2025 Personalized Cancer Immunotherapy: Driving Treatment Revolution
Editorial · 29 Aug 2025 Evolving Supportive Care in Cancer Immunotherapy: A Holistic Approach
This compilation of research focuses on comprehensive supportive care for patients receiving cancer immunotherapy. It addresses the management of immune-related adverse events (irAEs), the influence of the gut microbiome
Perspective · 14 Aug 2025 Cancer immunotherapy: Progress, challenges, future horizons
Conference abstract · 23 Jun 2025 Improving cervical cancer immunotherapy: Safe and specific tumor targeting via the UniCAR system
Cervical cancer (CC) is the second leading cause of cancer-related mortality in women worldwide. Despite advances in treatments such as chemotherapy, radiotherapy, and surgery, these therapies are often only…
Rapid communication · 29 May 2025 Harnessing the power of the immune system: Advances in cancer immunotherapy and molecular oncology research
Short communication · 10 Apr 2025 Discover the Role of Calorie Restriction in Cancer Immunotherapy
Nowadays, the development of cancer immunotherapy has brought breakthrough results in treatment. However, understanding of the limitations of this therapy remains unclear. While the significant role of dietary energy…

